Archives of disease in childhood. Fetal and neonatal edition · 2016
Stabilisation of premature infants in the delivery room with nasal high flow.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Reynolds Peter, Leontiadi Stamatina, Lawson Tracy, Otunla Tosin, Ejiwumi Olayinka, Holland Nicola
Аннотация
OBJECTIVE: This was a pilot study to determine the feasibility of using nasal high flow (nHF) (also known as heated humidified high-flow nasal cannula) for stabilisation of babies born at <30 weeks gestation in the delivery room (DR) and transfer to the neonatal intensive care unit (NICU).
DESIGN: Observational study.
SETTING: Single-centre NICU.
PATIENTS: Infants born at <30 weeks gestation.
INTERVENTIONS: Stabilisation and transfer to NICU using nHF.
MAIN OUTCOME MEASURES: Feasibility of stabilisation as defined by successful transfer and clinical measures of stability at admission to NICU including oxygen requirement, temperature, requirement for surfactant and inotrope use within 72 h of delivery.
RESULTS: Twenty-eight babies were enrolled after written parental consent had been obtained. 25/28 were successfully stabilised in the DR and transferred to the NICU on nHF. The average admission temperature for babies transferred on nHF was 36.9°C and the average inspired oxygen at admission was 29%. Less than half (48%) required surfactant and 60% were still on nHF 72 h after admission. 1 baby received inotropes.
CONCLUSIONS: Our study suggests that using nHF for stabilisation of premature infants in the DR and subsequent transfer to NICU is feasible.
CLINICAL TRIAL REGISTRATION NUMBER: NCT01991886.
DESIGN: Observational study.
SETTING: Single-centre NICU.
PATIENTS: Infants born at <30 weeks gestation.
INTERVENTIONS: Stabilisation and transfer to NICU using nHF.
MAIN OUTCOME MEASURES: Feasibility of stabilisation as defined by successful transfer and clinical measures of stability at admission to NICU including oxygen requirement, temperature, requirement for surfactant and inotrope use within 72 h of delivery.
RESULTS: Twenty-eight babies were enrolled after written parental consent had been obtained. 25/28 were successfully stabilised in the DR and transferred to the NICU on nHF. The average admission temperature for babies transferred on nHF was 36.9°C and the average inspired oxygen at admission was 29%. Less than half (48%) required surfactant and 60% were still on nHF 72 h after admission. 1 baby received inotropes.
CONCLUSIONS: Our study suggests that using nHF for stabilisation of premature infants in the DR and subsequent transfer to NICU is feasible.
CLINICAL TRIAL REGISTRATION NUMBER: NCT01991886.